Log In
Print
BCIQ
Print
Print this Print this
 

SAPPHIRE II eye test

  Manage Alerts
Collapse Summary General Information
Company Cognoptix Inc.
DescriptionLigand/contrast agent combined with a software-controlled optical instrument that allows for the non-invasive detection of a fluorescent signature of beta amyloid in the supranuclear region of the lens of the eye
Molecular Target Beta amyloid
Mechanism of ActionDiagnostic; Imaging agent
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPilot
Standard IndicationNeurology, Diagnostic
Indication DetailsEarly detection of Alzheimer's disease (AD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today